GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Gilvocarcin V (Lot S654-G96)

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act1615Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 59.0 100 -0.1 6/6Treatment schedule day 1 Dose, i.p.  mg/kg/injection 0.510.7164/antibiotics.34.266
act1611Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 511.5 128 -0.2 6/6Treatment schedule day 1 Dose, i.p.  mg/kg/injection 810.7164/antibiotics.34.266
act1619Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 59.0 100 +0.2 6/6Treatment schedule day 1, 5, 9 Dose, i.p.  mg/kg/injection 210.7164/antibiotics.34.266
act1609Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 513.0 144 -0.6 6/6Treatment schedule day 1 Dose, i.p.  mg/kg/injection 3210.7164/antibiotics.34.266
act1617Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 513.5 150 +0.2 6/6Treatment schedule day 1, 5, 9 Dose, i.p.  mg/kg/injection 810.7164/antibiotics.34.266
act1621Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 59.0 100 -0.1 6/6Treatment schedule day 1, 5, 9 Dose, i.p.  mg/kg/injection 0.510.7164/antibiotics.34.266
act1613Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 510.0 111 -0.2 5/5Treatment schedule day 1 Dose, i.p.  mg/kg/injection 210.7164/antibiotics.34.266
act1608Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 514.5 161 -0.3 6/6Treatment schedule day 1 Dose, i.p.  mg/kg/injection 6410.7164/antibiotics.34.266
act1614Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 59.0 100 -0.1 6/6Treatment schedule day 1 Dose, i.p.  mg/kg/injection 110.7164/antibiotics.34.266
act1618Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 510.5 117 +0.7 6/6Treatment schedule day 1, 5, 9 Dose, i.p.  mg/kg/injection 410.7164/antibiotics.34.266
act1610Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 511.0 122 -0.6 6/6Treatment schedule day 1 Dose, i.p.  mg/kg/injection 1610.7164/antibiotics.34.266
act1620Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 59.0 100 +0.6 6/6Treatment schedule day 1, 5, 9 Dose, i.p.  mg/kg/injection 110.7164/antibiotics.34.266
act1612Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 510.0 111 -0.9 6/6Treatment schedule day 1 Dose, i.p.  mg/kg/injection 410.7164/antibiotics.34.266
act1616Gilvocarcin V (Lot S654-G96)P388 leukemia (Exp. 6747)MST days\nEffect MST % T/C\nAWG g Day 4 \nSurvivors Day 513.0 144 0 5/5Treatment schedule day 1, 5, 9 Dose, i.p.  mg/kg/injection 1610.7164/antibiotics.34.266